How Cells Power Down During Viral Attack
A team of UF researchers has uncovered how cells temporarily shut down protein production during viral attack, a discovery that could shape future antiviral drug development.
UF News
LightPath Technologies Announces First Germanium-Free G5 Camera Variants Utilizing Proprietary BlackDiamond™ Glass
UF startup LightPath Technologies announced that its subsidiary G5 Infrared has begun producing two high-end cooled infrared cameras using LightPath’s proprietary BlackDiamond™ Glass instead of Germanium.
Tech Tuesday: Local Company Aims To Reduce Environment Pollution With Biodegradable Packaging
In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey features Ignition Packaging, a company developing biodegradable solutions to reduce environmental pollution.
AI Tool Speeds Acute Myeloid Leukemia Diagnosis
A team of UF researchers has developed a digital tool digital tool that uses artificial intelligence to accelerate the diagnosis of acute leukemia
New Lightning Sensors Could Detect Tahoe Wildfires in Seconds. Here’s How They Work
A real-time lightning detection system developed by UF Innovate | Accelerate resident client FNN is helping California officials better prepare for wildfires, offering earlier alerts to reduce disaster risk.
Assisted by Sniffer Dogs and DNA Sequencing, Researchers Discover Three New Truffle Species
UF researchers studying fungal evolution and ecology have discovered three new truffle species, including one capable of commanding hundreds of dollars per pound within culinary circles.
NIH Award Supports New Extracellular Vesicle Loading Platform To Develop Gene Therapy
UF researcher Mei He, Ph.D., has received a $1.3 million award from the National Institutes of Health to support a new extracellular vesicle platform used to develop gene therapy.
UF Researchers Get Closer to Saliva Test for Breast Cancer
UF researchers have improved a potentially transformative handheld device to detect breast cancer in saliva, simplifying the design and confirming its accuracy.
Oragenics Selects Southern Star Research As Clinical Research Organization for ONP-002 Phase IIa Trial
UF Innovate | Accelerate graduate Oragenics, Inc., announced the selection of Southern Star Research as its Clinical Research Organization (CRO) for the upcoming Phase IIa clinical trial of ONP-002, the company’s lead drug candidate for concussion.
‘Lifesaving’ Ketamine Offers New Hope for PTSD Sufferers
A UF study led by 2024 graduate Shahar Almog, Ph.D., reveals additional mental health benefits of ketamine, further supporting its potential as a treatment for depression and PTSD.
Want our news in your inbox every Monday morning? You can!